Amended Statement of Ownership (sc 13g/a)
14 Febrero 2022 - 9:59AM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
_____________
SCHEDULE 13G/A
(Rule 13d-102)
INFORMATION
TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(b),
(c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO
RULE 13d-2(b)
(Amendment
No. 1)
Champions
Oncology, Inc.
(Name of Issuer)
Common
Stock
(Title of
Class of Securities)
15870P307
(CUSIP Number)
December
31, 2021
(Date of Event
Which Requires Filing of This Statement)
Check the appropriate box
to designate the rule pursuant to which this Schedule is filed:
[ ] Rule
13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule
13d-1(d)
|
*
|
The remainder
of this cover page shall be filled out for a reporting person’s initial filing
on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter the disclosures provided in a prior
cover page.
|
The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).
(Continued on
following pages)
CUSIP NO. 15870P307
|
13G
|
Page
2 of 9 Pages
|
1
|
NAMES OF REPORTING PERSONS
WEST ELK PARTNERS, LP
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) [ ]
(b) [ ]
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
STATE OF DELAWARE, UNITED STATES OF AMERICA
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
N/A
|
6
|
SHARED VOTING POWER
1,093,387 shares of Common Stock
|
7
|
SOLE DISPOSITIVE POWER
N/A
|
8
|
SHARED DISPOSITIVE POWER
1,093,387 shares of Common Stock
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,093,387 shares
of Common Stock
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
[ ]
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.09% of
the outstanding shares of Common Stock
|
12
|
TYPE OF REPORTING PERSON
PN (Limited Partnership)
|
CUSIP NO. 15870P307
|
13G
|
Page
3 of 9 Pages
|
1
|
NAMES OF REPORTING PERSONS
WEST ELK, LLC
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) [ ]
(b) [ ]
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
STATE OF DELAWARE, UNITED STATES OF AMERICA
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
N/A
|
6
|
SHARED VOTING POWER
1,093,387 shares of Common Stock
|
7
|
SOLE DISPOSITIVE POWER
N/A
|
8
|
SHARED DISPOSITIVE POWER
1,093,387 shares of Common Stock
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,093,387 shares
of Common Stock
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
[ ]
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.09% of
the outstanding shares of Common Stock
|
12
|
TYPE OF REPORTING PERSON
OO (Limited Liability Company)
|
CUSIP
NO. 15870P307
|
13G
|
Page
4 of 9 Pages
|
1
|
NAMES
OF REPORTING PERSONS
WEST ELK CAPITAL, LLC
|
2
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
|
(a) [ ]
(b) [ ]
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
STATE OF DELAWARE, UNITED
STATES OF AMERICA
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
N/A
|
6
|
SHARED VOTING POWER
1,093,387 shares of Common
Stock
|
7
|
SOLE DISPOSITIVE POWER
N/A
|
8
|
SHARED DISPOSITIVE POWER
1,093,387 shares of Common
Stock
|
9
|
AGGREGATE AMOUNT BENEFICIALLY
OWNED BY EACH REPORTING PERSON
1,093,387 shares of Common
Stock
|
10
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
[ ]
|
11
|
PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW 9
8.09% of the outstanding
shares of Common Stock
|
12
|
TYPE OF REPORTING PERSON
OO (Limited Liability Company),
IA (Investment Adviser)
|
CUSIP NO. 15870P307
|
13G
|
Page
5 of 9 Pages
|
1
|
NAMES OF REPORTING PERSONS
Jason Joffe
|
2
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
|
(a) [ ]
(b) [ ]
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES OF AMERICA
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
N/A
|
6
|
SHARED VOTING POWER
1,093,387 shares of Common
Stock
|
7
|
SOLE DISPOSITIVE POWER
N/A
|
8
|
SHARED DISPOSITIVE POWER
1,093,387 shares of Common
Stock
|
9
|
AGGREGATE AMOUNT BENEFICIALLY
OWNED BY EACH REPORTING PERSON
1,093,387 shares of Common
Stock
|
10
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
[ ]
|
11
|
PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW 9
8.09% of the outstanding
Common Stock
|
12
|
TYPE OF REPORTING PERSON
IN (Individual)
|
CUSIP NO. 15870P307
|
13G
|
Page
6 of 9 Pages
|
1
|
NAMES OF REPORTING PERSONS
Morgan Duke
|
2
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
|
(a) [ ]
(b) [ ]
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES OF AMERICA
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
N/A
|
6
|
SHARED VOTING POWER
1,093,387 shares of Common
Stock
|
7
|
SOLE DISPOSITIVE POWER
N/A
|
8
|
SHARED DISPOSITIVE POWER
1,093,387 shares of Common
Stock
|
9
|
AGGREGATE AMOUNT BENEFICIALLY
OWNED BY EACH REPORTING PERSON
1,093,387 shares of Common
Stock
|
10
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
[ ]
|
11
|
PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW 9
8.09% of the outstanding
Common Stock
|
12
|
TYPE OF REPORTING PERSON
IN (Individual)
|
Item 1.
|
(a)
|
Name of Issuer:
|
Champions Oncology, Inc. (the “Issuer”)
|
(b)
|
Address of Issuer’s Principal Executive Offices:
|
One University Plaza
Suite 307
Hackensack, New Jersey 07601
|
Item 2.
|
(a)
|
Name of Persons Filing:
|
West Elk Partners, LP
West Elk, LLC
West Elk Capital, LLC
Jason Joffe
Morgan Duke
|
(b)
|
Address of Principal Business Office or, if None, Residence:
|
For all persons filing:
1175 Peachtree Street NE
Suite 360
Atlanta, GA 30361
West Elk Partners, LP is a Delaware limited
partnership
West Elk, LLC is a Delaware limited
liability company
West Elk Capital, LLC is a Delaware
limited liability company
Mr. Joffe and Mr. Duke are United States citizens
|
(d)
|
Title of Class of Securities:
|
Common Stock
15870P307
|
Item 3.
|
If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
|
Not applicable. Filed pursuant to Rule 13d-1(c).
|
West Elk Partners, LP
|
West Elk, LLC
|
West Elk Capital, LLC
|
Jason Joffe
|
Morgan Duke
|
(a)
|
Amount Beneficially Owned:
|
1,093,387
|
1,093,387
|
1,093,387
|
1,093,387
|
1,093,387
|
(b)
|
Percent of Class:
|
8.09%
|
8.09%
|
8.09%
|
8.09%
|
8.09%
|
(c)
|
Number of Shares to Which Reporting Person Has:
|
|
|
|
|
|
(i)
|
Sole Voting Power:
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
|
(ii)
|
Shared Voting Power:
|
1,093,387
|
1,093,387
|
1,093,387
|
1,093,387
|
1,093,387
|
|
(iii)
|
Sole Dispositive Power:
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
|
(iv)
|
Shared Dispositive Power:
|
1,093,387
|
1,093,387
|
1,093,387
|
1,093,387
|
1,093,387
|
The reported shares are
the Issuer’s common stock.
All of the reported shares
are owned directly by West Elk Partners, LP (“West Elk Partners”), whose general partner is West Elk, LLC (the “General
Partner”) and whose investment adviser is West Elk Capital, LLC (the “Investment Adviser”). The General Partner
and the Investment Adviser could each be deemed to be indirect beneficial owners of the reported shares, and could be deemed to
share such beneficial ownership with West Elk Partners.
Jason Joffe and Morgan Duke
are the managers of the General Partner and Investment Adviser, and could be deemed to share such indirect beneficial ownership
with the General Partner, the Investment Adviser, and West Elk Partners.
|
Item 5.
|
Ownership of Five Percent or
Less of a Class.
|
If this statement is being
filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following [ ].
|
Item 6.
|
Ownership of More than Five
Percent on Behalf of Another Person.
|
Not applicable.
|
Item 7.
|
Identification
and Classification of the Subsidiary That Acquired the Security Being Reported on by
the Parent Holding Company or Control Person.
|
Not applicable.
|
Item 8.
|
Identification and Classification
of Members of the Group.
|
Not applicable.
|
Item 9.
|
Notice
of Dissolution of Group.
|
Not applicable.
By
signing below, each of the undersigned certifies that, to the best of his or its knowledge and belief, the securities referred
to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having
that purpose or effect.
Signature
After
reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned certifies
that the information set forth in this Statement is true, complete and correct.
|
Date:
|
February 9, 2022
|
|
|
|
|
|
|
WEST ELK PARTNERS, LP
|
|
|
|
|
|
|
By:
|
West Elk, LLC, General Partner
|
|
|
|
|
|
|
By:
|
/s/ Jason Joffe
|
|
|
Name:
|
Jason Joffe
|
|
|
Title:
|
Manager
|
|
|
|
|
|
|
Date:
|
February 9, 2022
|
|
|
|
|
|
|
WEST ELK, LLC
|
|
|
|
|
|
|
By:
|
/s/ Jason Joffe
|
|
|
Name:
|
Jason Joffe
|
|
|
Title:
|
Manager
|
|
|
|
|
|
|
Date:
|
February 9, 2022
|
|
|
|
|
|
|
WEST ELK CAPITAL, LLC
|
|
|
|
|
|
|
By:
|
/s/ Jason Joffe
|
|
|
Name:
|
Jason Joffe
|
|
|
Title:
|
Manager
|
|
|
|
|
|
|
Date:
|
February 9, 2022
|
|
|
|
|
|
|
/s/ Jason Joffe
|
|
|
Jason Joffe
|
|
|
|
|
|
|
Date:
|
February 9, 2022
|
|
|
|
|
|
|
/s/ Morgan Duke
|
|
|
Morgan Duke
|
|
Champions Oncology (NASDAQ:CSBR)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Champions Oncology (NASDAQ:CSBR)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024